# Tranexamic Acid

NDC: 63323-563
Generic name: Tranexamic Acid
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20120524

FDA application: ANDA091596

## Active ingredients

- TRANEXAMIC ACID: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-563"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-563
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6c3da51-fc45-4d5c-b983-1576830c95dd